Higher values of most cardiometabolic risk factors assessed in the current study, correlating with baseline prolactin levels, indicate that even mild-to-moderate prolactin excess is associated with an increased risk of development of cardiovascular disease and carbohydrate disorders, and that this risk is proportional to the degree of hyperprolactinemia. The gene discussed is PRL; the disease is hyperprolactinemia.